Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|September 24, 2004
Redifferentiation therapy in advanced thyroid cancerBryan R HaugenEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 2, 2012
Radioiodine remnant ablation: current indications and dosing regimensBryan R HaugenBest Practice & Research. Clinical Endocrinology & Metabolism|November 28, 2009
Drugs that suppress TSH or cause central hypothyroidismBryan R HaugenEndocrine Reviews|April 12, 2013
Evolving approaches to patients with advanced differentiated thyroid cancerBryan R Haugen, Steven I ShermanEndocrinology and Metabolism Clinics of North America|February 6, 2019
Molecular Diagnostic Evaluation of Thyroid NodulesSarah E Mayson, Bryan R HaugenEndocrinology and Metabolism (Seoul, Korea)|January 6, 2023
Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse ModelsMin Ji Jeon, Bryan R HaugenClinical Endocrinology|July 27, 2004
Uses for recombinant human TSH in patients with thyroid cancer and nodular goiterWhitney W Woodmansee, Bryan R HaugenThe Journal of Clinical Endocrinology and Metabolism|March 6, 2010
Approach to the thyroid cancer patient with extracervical metastasesBryan R Haugen, Madeleine A KaneLancet (London, England)|May 15, 2013
Progress in molecular-based management of differentiated thyroid cancerMingzhao Xing, Bryan R Haugen, Martin SchlumbergerPageof 11